Which drug is associated with Schedule IV classification?

Zolpidem is classified as a Schedule IV controlled substance due to its potential for abuse and dependence, albeit lower than that of substances classified as Schedule I-III. As a sedative-hypnotic medication, it is primarily used for the treatment of insomnia. Schedule IV drugs are acknowledged for having accepted medical uses but still possess a risk of addiction and abuse, which necessitates regulation by authorities such as the Drug Enforcement Administration (DEA).

In comparison, lacosamide is used for seizure management and is classified as a Schedule V substance, which carries a lower potential for abuse. Hydrocodone, commonly used in pain management, is classified as Schedule II due to its higher potential for addiction and abuse. Fiorenal, which contains aspirin, butalbital, and caffeine, is sometimes considered Schedule III or IV depending on state regulations, but it is mainly the butalbital component that raises concern regarding dependence. Thus, the choice of Zolpidem aligns with the characteristics of Schedule IV substances, highlighting its proper classification in the context of drug scheduling.